Clinical Trial Update: Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine [Phase 3]

View source ↗

Summary

This is a Phase 3 study comparing the 13-valent pneumococcal conjugate vaccine with the 7-valent vaccine. The trial status is completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar (pneumococcal conjugate vaccine)
• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Vaccines, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2013-02-21